Obesity and asthma: beyond T(H)2 inflammation.

Area of Science:

• Immunology
• Endocrinology
• Pulmonology

Background:

• Obesity is a significant risk factor for asthma development and severity.
• Obesity impairs the effectiveness of standard asthma medications, leading to poorer asthma control.
• Certain asthma phenotypes, particularly those linked to obesity, may not involve typical T(H)2-dependent inflammation.

Purpose of the Study:

• To investigate the mechanisms underlying asthma in obese individuals.
• To explore T(H)2-independent pathways contributing to obesity-related asthma.
• To understand how hormonal and neural factors in obesity impact asthma.

Main Methods:

• Review of current scientific literature on obesity and asthma.
• Analysis of T(H)2-independent inflammatory and non-inflammatory pathways.
• Examination of the role of hormones in glucose homeostasis and obesity pathogenesis.
• Investigation of endocrine regulation of airway nerves and airway hyperreactivity (AHR).

Main Results:

• Growing evidence suggests obesity-related asthma phenotypes differ from classical T(H)2-driven inflammation.
• Hormones regulating glucose and obesity may link obesity and asthma via inflammatory and non-inflammatory routes.
• Endocrine regulation of airway nerves likely contributes to airway hyperreactivity in obesity.

Conclusions:

• The mechanisms of obesity-related asthma may not rely on T(H)2-dependent inflammation.
• Understanding T(H)2-independent pathways is crucial for managing asthma in obese patients.
• Hormonal and neural dysregulation in obesity plays a key role in asthma pathogenesis.